Glucose point-of-care testing in the neonatal intensive care unit, as the basis for informing clinical decision-making and treatment of neonatal hypoglycemia, has been extensively adopted as a preferred clinical tool, given its ease of use and minimal blood volume requirement to obtain a timely bedside glucose result.
Martha E. Lyon
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Martha E.
Contact Martha E., search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack